[ad_1]
In April 2014, after drug maker Mylan increased prices for more than seven of its drugs, Teva Pharmaceutical Industries, the largest generic drug company in the world and one of Mylan's biggest rivals, reportedly also wanted to raise its prices.
Four days later, four employees later, Teva employees shared detailed information about Mylan's price increases internally, according to a new lawsuit filed by 44 states against Teva, Mylan and 18 other generic drug companies.
Business Insider has obtained an unedited copy of the complaint, which relates alleged communications between employees of competing companies via email, Facebook message and spreadsheets. The goal was to coordinate drug prices and client transactions, according to the complaint.
The prosecution is the second case in a state generic drug investigation, generally considered an inexpensive treatment option. The complaints led to a re-examination of drug prices and commercial practices of generic drug manufacturers.
Teva denied any criminal or civil liability and stated that he would defend himself vigorously. Mylan also stated that the complaint contained "unproven allegations" and that he was considering defending himself.
SUBSCRIBE TO READ OUR HISTORY: In the secret messages supposed to show how big pharmaceutical companies have planned to increase the price of your drugs
Source link
